or Try an Advanced Search...

    Technical Analysis for CRSP - CRISPR Therapeutics AG

    Grade Last Price % Change Price Change
    F 53.91 0.34% 0.18
    CRSP closed up 0.34 percent on Friday, April 26, 2024, on 82 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 6
    *** please verify all earnings dates ***
    11 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CRSP trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish 0.34%
    NR7 Range Contraction 0.34%
    Narrow Range Bar Range Contraction 0.34%
    Wide Bands Range Expansion 0.34%
    Gapped Down Weakness 0.34%
    Oversold Stochastic Weakness 0.34%
    Wide Bands Range Expansion -3.13%
    Oversold Stochastic Weakness -3.13%
    Older End-of-Day Signals for CRSP ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 21 hours ago
    Up 1% about 22 hours ago
    Hammer Candlestick Entry about 22 hours ago
    Rose Above Previous Day's High about 22 hours ago
    Down 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CRSP Chart by TradingView
    Basic chart:

    Profile

    Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9

    Is CRSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note
    Apr 25 Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
    Apr 24 Crispr Therapeutics: Now Is The Time To Buy
    Apr 22 CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
    Apr 22 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
    Apr 22 Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks
    Apr 20 CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
    Apr 19 ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential
    Apr 17 Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
    Apr 15 TD Cowen says sickle cell therapies may get higher CMS payments
    See more CRSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 91.1
    52 Week Low 37.55
    Average Volume 1,646,136
    200-Day Moving Average 59.46
    50-Day Moving Average 70.89
    20-Day Moving Average 59.96
    10-Day Moving Average 55.88
    Average True Range 2.77
    RSI (14) 26.47
    ADX 33.37
    +DI 13.72
    -DI 31.78
    Chandelier Exit (Long, 3 ATRs) 63.23
    Chandelier Exit (Short, 3 ATRs) 61.06
    Upper Bollinger Bands 68.84
    Lower Bollinger Band 51.07
    Percent B (%b) 0.16
    BandWidth 29.64
    MACD Line -4.43
    MACD Signal Line -4.25
    MACD Histogram -0.181
    Fundamentals Value
    Market Cap 4.28 Billion
    Num Shares 79.4 Million
    EPS -4.47
    Price-to-Earnings (P/E) Ratio -12.06
    Price-to-Sales 34.65
    Price-to-Book 3.22
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 57.09
    Resistance 3 (R3) 57.08 56.01 56.56
    Resistance 2 (R2) 56.01 55.20 56.01 56.38
    Resistance 1 (R1) 54.96 54.70 54.42 54.97 56.21
    Pivot Point 53.89 53.89 53.62 53.89 53.89
    Support 1 (S1) 52.84 53.08 52.30 52.85 51.61
    Support 2 (S2) 51.77 52.58 51.77 51.44
    Support 3 (S3) 50.72 51.77 51.26
    Support 4 (S4) 50.73